Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease
Biomolecules · 19.05.2023 · 13 (5) · 865
DOI: 10.3390/biom13050865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 19.05.2023. Verfasst von Lorenzo Agostino Citterio und 4 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Fondazione Don Carlo Gnocchi ONLUS, 20148 Milan, Italy. Hauptthemen laut MEDLINE: Parkinson Disease, MicroRNAs. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, PNRR Project MNESYS, Fondazione Alessandro e Vincenzo Negroni Prati Morosini.
Abstract (Originalsprache)
The etiology of Parkinson’s disease (PD) is poorly understood, and is strongly suspected to include both genetic and environmental factors. In this context, it is essential to investigate possible biomarkers for both prognostic and diagnostic purposes. Several studies reported dysregulated microRNA expression in neurodegenerative disorders, including PD. Using ddPCR, we investigated the concentrations of miR-7-1-5p, miR-499-3p, miR-223-3p and miR-223-5p—miRNAs involved in the α-synuclein pathway and in inflammation—in the serum and serum-isolated exosomes of 45 PD patients and 49 age- and sex-matched healthy controls (HC). While miR-499-3p and miR-223-5p showed no differences (1), serum concentration of miR-7-1-5p was significantly increased (p = 0.0007 vs. HC) and (2) miR-223-3p serum (p = 0.0006) and exosome (p = 0.0002) concentrations were significantly increased. ROC curve analysis showed that miR-223-3p and miR-7-1-5p serum concentration discriminates between PD and HC (p = 0.0001, in both cases). Notably, in PD patients, both miR-223-3p serum (p = 0.0008) and exosome (p = 0.006) concentrations correlated with levodopa equivalent daily dosage (LEDD). Finally, serum α-synuclein was increased in PD patients compared to HC (p = 0.025), and in patients correlated with serum miR-7-1-5p in (p = 0.05). Our results suggest that both miR-7-1-5p and miR-223-3p, distinguishing PD from HC, have the potential to be useful and non-invasive biomarkers in Parkinson’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Fondazione Don Carlo Gnocchi ONLUS, 20148 Milan, Italy.
- Department of Pathophysiology and Transplantation, University of Milan, 20100 Milan, Italy.
ORCID-Profile: Lorenzo Agostino Citterio, Roberta Mancuso, Simone Agostini, Mario Clerici
Förderung
- Italian Ministry of Health
- PNRR Project MNESYS
- Fondazione Alessandro e Vincenzo Negroni Prati Morosini
- Fondazione Romeo ed Enrica Invernizzi
Zitieren
APA
Citterio, L. A., Mancuso, R., Agostini, S., Meloni, M., & Clerici, M. (2023). Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease. Biomolecules, 13(5), 865. https://doi.org/10.3390/biom13050865
Vancouver
Citterio LA, Mancuso R, Agostini S, Meloni M, Clerici M. Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease. Biomolecules. 2023;13(5):865. doi:10.3390/biom13050865
BibTeX
@article{Citterio2023,
author = {Citterio, Lorenzo Agostino and Mancuso, Roberta and Agostini, Simone and Meloni, Mario and Clerici, Mario},
title = {Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {5},
pages = {865},
doi = {10.3390/biom13050865}
}
EUVIMED